Nanovibronix Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The firm's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
Follow-Up Questions
Qui est le CEO de Nanovibronix Inc ?
Mr. Brian Murphy est le Chief Executive Officer de Nanovibronix Inc, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action NAOV ?
Le prix actuel de NAOV est de $7.21, il a increased de 7.45% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Nanovibronix Inc ?
Nanovibronix Inc appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de Nanovibronix Inc ?
La capitalisation boursière actuelle de Nanovibronix Inc est de $5.7M
